Genomic damage in the progression of chronic kidney disease in rats

Brain, Behavior, and Immunity

Volumn 25, Issue 3, 2011, Pages 416-422

  Hirotsu, Camila ^a   Tufik, Sergio ^a   Ribeiro, Daniel A ^a   Alvarenga, Tathiana A ^a   Andersen, Monica L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer; Chronic kidney disease; DNA damage; Rats; Uremia

Indexed keywords

IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CHRONIC KIDNEY DISEASE; COMET ASSAY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DNA DAMAGE; GENOME; GENOTOXICITY; IRON BLOOD LEVEL; KIDNEY CELL; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; COMET ASSAY; CYTOKINES; DISEASE PROGRESSION; DNA DAMAGE; KIDNEY; KIDNEY FAILURE, CHRONIC; LIVER; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 79551688074     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.021     Document Type: Article

References (42)

1. Alvarenga T., Andersen M.L., Ribeiro D.A., Araujo P., Hirotsu C., Costa J.L., Battisti M.C., Tufik S. Single exposure to cocaine or ecstasy induces DNA damage in brain and other organs of mice. Addict. Biol. 2010, 15:96-99.
2. Andersen M.L., Ribeiro D.A., Bergamaschi C.T., Alvarenga T.A., Silva A., Zager A., Campos R.R., Tufik S. Distinct effects of acute and chronic sleep loss on DNA damage in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:562-567.
3. Balakrishnan V.S., Schmid C.H., Jaber B.L., Natov S.N., King A.J., Pereira B.J. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells: a novel predictor of morbidity among hemodialysis patients. J. Am. Soc. Nephrol. 2000, 11:2114-2121.
4. Cengiz K. Increased incidence of neoplasia in chronic renal failure (20-year experience). Int. Urol. Nephrol. 2002, 33:121-126.
5. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17:1195-1214.
6. Demple H., Linn B., Hallbrook J. Escherichia coli with mutants are hypersensitive to hydrogen peroxide. J. Bacteriol. 1983, 153:1079-1082.
7. Fitzpatrick F.A. Inflammation, carcinogenesis and cancer. Int. Immunopharmacol. 2001, 1:1651-1667.
8. Giacchino F., Pozzato M., Formica M., Pellerey M., Quattrocchio G., Comune L., Berto M., Piccoli G. Neoplasms in chronic kidney failure. Minerva Nefrol. 1983, 30:33-35.
9. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson B., Clay P., Collins A., Smith A., Speit G., Thybaud V., Tice R.R. Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis 2003, 18:45-51.
10. Hoffmann H., Speit G. Assessment of DNA damage in peripheral blood of heavy smokers with the comet assay and the micronucleus test. Mutat. Res. 2005, 581:105-114.
11. Inamoto H., Ozaki R., Matsuzaki T., Wakui M., Saruta T., Osawa A. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 1991, 59:611-617.
12. Jagadeesan V., Rao N.J., Sesikeran B. Effect of iron deficiency on DMH-induced gastrointestinal tract tumors and occurrence of hepatocyte abnormalities in Fischer rats. Nutr. Cancer 1994, 22:285-291.
13. Kan E., Undeĝer U., Bali M., Başaran N. Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation. Mutat. Res. 2002, 520:151-159.
14. Kassie F., Parzefall W., Knasmuller S. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat. Res. 2000, 463:13-31.
15. McKelvey-Martin V.J., Green M.H., Schmezer P., Pool-Zoble B.L., De Méo M.P., Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat. Res. 1993, 288:47-63.
16. Møller P., Möller L., Godschalk R.W., Jones G.D. Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis 2010, 25:109-111.
17. Mueller M., Peters F.T., Maurer H.H., McCann U.D., Ricaurte G.A. Nonlinear pharmacokinetics of (+/-) 3,4-methylenedioxymethamphetamine (MDMA, " Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J. Pharmacol. Exp. Ther. 2008, 327:38-44.
18. Nielsen V.K. The peripheral nerve function in chronic renal failure. VI: The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex and clinical neuropathy. Acta Med. Scand. 1973, 194:455-462.
19. Nielsen V.K. The peripheral nerve function in chronic renal failure. VIII: Recovery after renal transplantation. Clinical aspects. Acta Med. Scand. 1974, 195:163-170.
20. Nishi E.E., Campos R.R., Bergamaschi C.T., de Almeida V.R., Ribeiro D.A. Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats. Hum. Exp. Toxicol. 2010, 29:593-599.
21. Podjarny E., Bernheim J., Hasdan G., Karsh D., Rashid G., Green J., Katz B., Bernheim J. Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy. Nephrol. Dial. Transplant. 2007, 22:1864-1872.
22. Quiroz Y., Ferrebuz A., Romero F., Vaziri N.D., Rodriguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am. J. Physiol. Renal. Physiol. 2008, 294:336-344.
23. Raji M.A., Kuo Y.F., Salazar J.A., Satish S., Goodwin J.S. Ethnic differences in antihypertensive medication use in the elderly. Ann. Pharmacother. 2004, 38:209-214.
24. Rao J., Jagadeesan V. Lipid peroxidation and activities of antioxidant enzymes in iron deficiency and effect of carcinogen feeding. Free Radic. Biol. Med. 1996, 21:103-108.
25. Ribeiro D.A., Salvadori D.M., Marques M.E. Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide. Int. J. Exp. Pathol. 2005, 86:375-381.
26. Ribeiro D.A., de Oliveira G., de Castro G., Angelieri F. Cytogenetic biomonitoring in patients exposed to dental X-rays: comparison between adults and children. Dentomaxillofac. Radiol. 2008, 37:404-407.
27. Ribeiro D.A., Campos R.R., Bergamaschi C.T. Chronic renal failure induces genetic instability in multiple organs of Wistar rats. Eur. J. Clin. Invest. 2009, 39:289-295.
28. Rocha M.E., Ferreira A.M., Bechara E.J. Roles of phosphate and an enoyl radical in ferritin iron mobilization by 5-aminolevulinic acid. Free Radic. Biol. Med. 2000, 29:1272-1279.
29. Rysz J., Banach M., Cialkowska-Rysz A., Stolarek R., Barylski M., Drozdz J., Okonski P. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell. Mol. Immunol. 2006, 3:151-154.
30. Sasaki Y.F., Kawaguchi S., Kamaya A., Ohshita M., Kabasawa K., Iwama K., Taniguchi K., Tsuda S. The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat. Res. 2002, 519:103-119.
31. Schupp N., Stopper H., Rutkowiski P., Kobras K., Nebel M., Bahner U., Vienken J., Heidland A. Effect of different hemodialysis regimens on genomic damage in end-stage renal failure. Semin. Nephrol. 2006, 26:28-32.
32. Schupp N., Schmid U., Rutkowski P., Lakner U., Kanase N., Heidland A., Stopper H. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am. J. Physiol. Renal. Physiol. 2007, 292:1427-1434.
33. Schupp N., Shmid U., Heidland A., Stopper H. New approaches for the treatment of genomic damage in end-stage renal disease. J. Ren. Nutr. 2008, 18:127-133.
34. Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M., Heimbürger O., Cederholm T., Girndt M. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int. 2005, 67:1216-1233.
35. Stopper H., Boullay F., Heidland A., Vienken J., Bahner U. Comet-assay analysis indentifies genomic damage in lymphocytes of uremic patients. Am. J. Kidney Dis. 2001, 38:296-301.
36. Stopper H., Schupp N., Klassen A., Sebekova K., Heidland A. Genomic damage in chronic renal failure - potential therapeutic interventions. J. Ren. Nutr. 2005, 15:81-86.
37. Strauch M., Gretz N. Animal models to induce renal failure: a historical survey. Contrib. Nephrol. 1988, 60:1-8.
38. Teschner M., Kosch M., Schaefer R.M. Folate metabolism in renal failure. Nephrol. Dial. Transplant. 2002, 17:24-27.
39. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
40. Vamvakas S., Bahner U., Heidland A. Increased cancer incidence in terminal kidney failure: potential pathogenetic mechanisms. Schweiz. Med. Wochenschr. 1997, 127:597-604.
41. Wong G., Hayen A., Chapman J.R., Webster A.C., Wang J.J., Mitchell P., Craig J.C. Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 2009, 20:1341-1350.
42. Zhang Z., Dmitrieva N.I., Park J.H., Levine R.L., Burg M.B. High urea and NaCl carbonylate proteins in renal cells in culture and in vivo, and high urea causes 8-oxoguanine lesions in their DNA. Proc. Natl. Acad. Sci. USA 2004, 101:9491-9496.